CN102302569B - Chinese medicinal composition for promoting lead discharging effect - Google Patents
Chinese medicinal composition for promoting lead discharging effect Download PDFInfo
- Publication number
- CN102302569B CN102302569B CN 201110265420 CN201110265420A CN102302569B CN 102302569 B CN102302569 B CN 102302569B CN 201110265420 CN201110265420 CN 201110265420 CN 201110265420 A CN201110265420 A CN 201110265420A CN 102302569 B CN102302569 B CN 102302569B
- Authority
- CN
- China
- Prior art keywords
- lead
- chinese medicine
- medicine composition
- parts
- radix paeoniae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000694 effects Effects 0.000 title claims abstract description 21
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 230000001737 promoting effect Effects 0.000 title abstract description 6
- 238000007599 discharging Methods 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 31
- 239000002994 raw material Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims 2
- 241001604597 Pyrestini Species 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 210000000582 semen Anatomy 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 14
- 241000408747 Lepomis gibbosus Species 0.000 abstract description 11
- 235000020236 pumpkin seed Nutrition 0.000 abstract description 11
- 241001092090 Pittosporum Species 0.000 abstract description 7
- 239000003205 fragrance Substances 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 7
- 210000000988 bone and bone Anatomy 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 240000002547 Rosa roxburghii Species 0.000 abstract description 3
- 235000000640 Rosa roxburghii Nutrition 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 3
- 210000000952 spleen Anatomy 0.000 abstract description 3
- 230000029142 excretion Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000001603 reducing effect Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 206010027439 Metal poisoning Diseases 0.000 description 6
- 208000008127 lead poisoning Diseases 0.000 description 6
- 240000001439 Opuntia Species 0.000 description 4
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- RXDLGFMMQFNVLI-UHFFFAOYSA-N [Na].[Na].[Ca] Chemical compound [Na].[Na].[Ca] RXDLGFMMQFNVLI-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940070748 dimercaptosuccinate Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- AVVSGTOJTRSKRL-UHFFFAOYSA-L hydrogen phosphate;lead(2+) Chemical compound [Pb+2].OP([O-])([O-])=O AVVSGTOJTRSKRL-UHFFFAOYSA-L 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- BCWRXLLYMXFJDY-UHFFFAOYSA-M sodium;4-hydroxy-4-oxo-2,3-bis(sulfanyl)butanoate Chemical compound [Na+].OC(=O)C(S)C(S)C([O-])=O BCWRXLLYMXFJDY-UHFFFAOYSA-M 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种具有促进排铅作用的中药组合物。采用的技术方案是:由以下原料药按重量份配比制成:赤芍5-20份、刺梨根10-30份、海桐皮10-30份、木香10-20份、南瓜子10-30份。本发明中,赤芍、海桐皮起到清热作用;南瓜子、刺梨根起到健脾利水作用,木香起到行气作用;几味药材科学配伍,能达到促进排铅、缓解或预防铅对人体损害、改善症状的目的,且无毒副作用,适合于血铅偏高人群长期服用。本发明中各原料易得,制作成本低,由于采用纯天然的中药材,因此制品的毒副作用小。经实践,本发明的中药组合物对血铅、骨铅、肝铅和脑铅具有明显的降低效果。The invention relates to a traditional Chinese medicine composition capable of promoting lead excretion. The technical scheme adopted is: the following raw materials are prepared according to the weight ratio : 5-20 parts of Radix Paeoniae Rubra, 10-30 parts of Rosa Roxburghii root, 10-30 parts of Pittosporum bark, 10-20 parts of woody fragrance, pumpkin seeds 10-30 servings. In the present invention, Radix Paeoniae Rubra and Pittodia bark play the role of clearing away heat; pumpkin seeds and roxburghii root play the role of invigorating the spleen and diuresis; The purpose is to prevent lead from harming the human body and improve symptoms, and has no toxic and side effects. It is suitable for long-term use by people with high blood lead. In the present invention, each raw material is easy to obtain, the production cost is low, and because pure natural Chinese medicinal materials are used, the toxic and side effects of the product are small. Through practice, the traditional Chinese medicine composition of the present invention has obvious reducing effects on blood lead, bone lead, liver lead and brain lead.
Description
技术领域 technical field
本发明属于中药领域,具体地说涉及一种具有促进排铅功能的中药组合物。 The invention belongs to the field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition with the function of promoting lead excretion.
背景技术 Background technique
随着城市化和工业化进程的加速,环境铅污染日趋严重,甚至影响到人类的健康。环境中的铅可通过呼吸道和皮肤进入人体,并以磷酸氢铅的形式分布于全身,其中有90-95%转化为正磷酸盐沉积于骨骼、牙齿、内脏、肌肤、毛发中,然后缓慢地转移到血液中(在血液中铅的理想浓度为零),对人体各组织系统造成危害,其中以神经系统和造血系统对铅最为敏感。 With the acceleration of urbanization and industrialization, environmental lead pollution is becoming more and more serious, even affecting human health. Lead in the environment can enter the human body through the respiratory tract and skin, and is distributed throughout the body in the form of lead hydrogen phosphate, of which 90-95% is converted into orthophosphate and deposited in bones, teeth, internal organs, skin, and hair, and then slowly Transferred into the blood (the ideal concentration of lead in the blood is zero), causing harm to various tissue systems of the human body, among which the nervous system and the hematopoietic system are the most sensitive to lead.
铅是一种人体非必需元素,它对机体组织有很强的亲和力,并通过影响人体必需的元素,扰乱人体中必需元素的生理组合及比例关系的平衡,从而扰乱机体内酶系统及生物大分子的生理活性,使机体内酶系统失去正常生理活性及其他调节机体功能平衡的调节作用发生紊乱,进而影响人体多个系统。具体表现为:影响智力的发育和骨骼发育,造成消化不良和内分泌失调,导致贫血、高血压和心律失常,破坏肾功能和免疫功能等。此外,铅还具有致癌的作用。 Lead is a non-essential element for the human body. It has a strong affinity for body tissues, and by affecting the essential elements of the human body, it disturbs the balance of the physiological combination and proportional relationship of the essential elements in the human body, thereby disturbing the enzyme system in the body and the biomacro. The physiological activity of the molecule will cause the enzyme system in the body to lose its normal physiological activity and other regulation functions that regulate the balance of body functions will be disordered, thereby affecting multiple systems of the human body. The specific manifestations are: affecting the development of intelligence and bone development, causing indigestion and endocrine disorders, leading to anemia, high blood pressure and arrhythmia, and destroying kidney function and immune function. In addition, lead also has carcinogenic effects.
按照国际儿童铅中毒诊断标准(血铅值>100ug/L),我国城市儿童铅中毒流行率在30%-40%之间,部分城市工业污染区将近100%,即使是没有明显工业污染的普通市区,也有10%-30%的儿童血铅超标。铅对健康的潜在危害,已日益引起人们的关注。 According to the international diagnostic standard for lead poisoning in children (blood lead value>100ug/L), the prevalence rate of lead poisoning in urban children in my country is between 30% and 40%, and the industrial pollution area in some cities is nearly 100%. In urban areas, 10%-30% of children's blood lead exceeds the standard. The potential harm of lead to health has attracted people's attention day by day.
目前,防治铅中毒的基本原则是环境干预、健康教育和临床治疗三者相结合,环境干预是根本,健康教育是基本手段,而对中度以上的铅中毒才考虑药物治疗。临床治疗铅中毒的药物主要有依地酸二钠钙(CaNa2EDTA)、二巯基丁二酸钠(DMSA)等,这些药物驱铅虽能降低体内铅负荷,排铅效果好,但却会使人体必需微量元素流失,也会对肾造成损害,副作用较大,而且驱铅药物对铅造成的神经损害逆转意义不大,所以药物排铅除中重度铅中毒外,临床一般不采用。 At present, the basic principle of prevention and treatment of lead poisoning is the combination of environmental intervention, health education and clinical treatment. Environmental intervention is fundamental, health education is the basic means, and drug treatment is only considered for moderate and above lead poisoning. The drugs for the clinical treatment of lead poisoning mainly include disodium calcium edetate (CaNa2EDTA), sodium dimercaptosuccinate (DMSA), etc. Although these drugs can reduce the lead load in the body and have a good lead-expelling effect, they will make the human body The loss of essential trace elements will also cause damage to the kidneys, and the side effects are relatively large, and lead-dispelling drugs have little significance in reversing the nerve damage caused by lead. Therefore, except for moderate to severe lead poisoning, drugs are generally not used in clinical practice.
发明内容 Contents of the invention
为了解决以上问题,本发明提供一种成本低、排铅效果好、毒副作用小的促进排铅的中药组合物。 In order to solve the above problems, the present invention provides a traditional Chinese medicine composition for promoting lead removal with low cost, good effect of lead removal and less toxic and side effects.
本发明采用的技术方案是:一种具有促进排铅作用的中药组合物,由以下原料药按重量份配比制成: The technical scheme adopted in the present invention is: a kind of traditional Chinese medicine composition that has the effect of promoting lead discharge, is made from the following raw materials in proportion by weight :
赤芍 5-20份 Paeoniae Rubra 5-20 parts
刺梨根 10-30份 10-30 servings of prickly pear root
海桐皮 10-30份 10-30 copies of pituitary bark
木香 10-20份 Woody fragrance 10-20 parts
南瓜子 10-30份 。 10-30 servings of pumpkin seeds.
本发明以上述中药组合物为有效成分,可按常规工艺制备成口服制剂,如水煎剂、口服液、胶囊、片剂等。 The present invention uses the above-mentioned traditional Chinese medicine composition as an active ingredient, and can be prepared into oral preparations according to conventional techniques, such as water decoction, oral liquid, capsules, tablets and the like.
优选的制备方法如下: The preferred preparation method is as follows:
1)按上述的重量份配比,称取各原料药备用; 1) According to the above weight ratio, weigh each raw material for later use;
2)加各原料药总重量8-10倍量水浸泡2-3小时,加热煎煮,煎煮液过滤;药渣再加8-10倍量水加热,煎煮液过滤,滤液合并,得上清液; 2) Add 8-10 times the total weight of each raw material, soak in water for 2-3 hours, heat and decoct, and filter the decoction; add 8-10 times the amount of water to the medicinal residues, heat the decoction, filter the decoction, and combine the filtrates to obtain supernatant;
3)上清液浓缩至相对密度为1.05-1.06时,进喷雾干燥器,进风温度控制130-140℃,出风温度100-110℃,进料速度为3-6 ml/分钟,得喷雾干燥粉。 3) When the supernatant is concentrated to a relative density of 1.05-1.06, it enters the spray dryer, the inlet air temperature is controlled at 130-140°C, the outlet air temperature is 100-110°C, and the feed rate is 3-6 ml/min to obtain a spray dry powder.
将喷雾干燥粉进一步按常规工艺制备口服液、胶囊、片剂或冲剂等。 The spray-dried powder is further prepared into oral liquid, capsule, tablet or granule etc. according to a conventional process.
本发明的有益效果是:赤芍,苦,微寒,归肝经,功效为清热凉血,散瘀止痛;刺梨根甘,酸,涩,健脾胃,止泻;海桐皮味苦,平,归肝、肾经,清热祛风止痛;木香,甘,辛,行气止痛;南瓜子,甘,性平,归大肠经,功效利水消肿。上述中药组合,起到了清热健胃、行气止痛功效。 The beneficial effect of the present invention is: Radix Paeoniae Rubra, bitter, be slightly cold, return Liver Meridian, effect is heat-clearing and cooling blood, dissipating blood stasis and relieving pain; Rosa roxburghii root is sweet, sour, astringent, invigorates the spleen and stomach, stops diarrhea; Flat, returns to liver, kidney meridian, clears away heat and relieves pain; woody fragrance, sweet, pungent, promotes qi and relieves pain; pumpkin seed, sweet, flat in nature, returns to large intestine meridian, has the effect of diuresis and detumescence. The above-mentioned combination of traditional Chinese medicines has played the effects of clearing away heat and invigorating the stomach, promoting qi circulation and relieving pain.
本发明中,赤芍、海桐皮起到清热作用;南瓜子、刺梨根起到健脾利水作用,木香起到行气作用;几味药材科学配伍,能达到促进排铅、缓解或预防铅对人体损害、改善症状的目的,且无毒副作用,适合于血铅偏高人群长期服用。本发明中各原料易得,制作成本低,由于采用纯天然的中药材,因此制品的毒副作用小。经实践,本发明的中药组合物对血铅、骨铅、肝铅和脑铅具有明显的降低效果。 In the present invention, Radix Paeoniae Rubra and Pittodia bark play a role in clearing heat; pumpkin seeds and roxburghii root play a role in invigorating the spleen and diuresis; The purpose is to prevent lead from harming the human body and improve symptoms, and has no toxic and side effects. It is suitable for long-term use by people with high blood lead. In the present invention, each raw material is easy to obtain, the production cost is low, and because pure natural Chinese medicinal materials are used, the toxic and side effects of the product are small. Through practice, the traditional Chinese medicine composition of the present invention has obvious reducing effects on blood lead, bone lead, liver lead and brain lead.
具体实施方式 Detailed ways
实施例1 具有促进排铅作用的中药组合物Embodiment 1 has the Chinese medicine composition that promotes the effect of excreting lead
(一)原料药重量份配比如下: (1) The weight ratio of raw materials is as follows:
赤芍 50克 Radix Paeoniae Alba 50g
刺梨根 100克 Prickly pear root 100g
海桐皮 100克 Pittosporum peel 100g
木香 100克 Woody Fragrance 100g
南瓜子 100克 100g pumpkin seeds
(二)制备方法如下: (2) The preparation method is as follows:
1)按上述重量份配比取原料药; 1) Take the raw material medicine according to the above weight ratio;
2)加入赤芍、刺梨根、海桐皮、木香和南瓜子总重量10倍量水浸泡2小时,加热煎煮,沸后过滤;药渣再加8倍量水加热至沸,沸后过滤,滤液合并,得上清液,即为水煎剂。 2) Add red peony root, Rosa roxburghii root, Pittosporum peel, wood incense and pumpkin seeds, soak in water for 2 hours, heat and decoct, and filter after boiling; add 8 times the amount of water to the dregs, heat to boil, and boil After filtering, the filtrates were combined to obtain a supernatant, which was a water decoction.
实施例2 具有促进排铅作用的中药组合物Embodiment 2 has the Chinese medicine composition that promotes the effect of excreting lead
(一)原料药重量份配比如下 (1) The weight ratio of raw materials is as follows
赤芍 200克 Radix Paeoniae Alba 200g
刺梨根 300克 Prickly pear root 300g
海桐皮 300克 Pittosporum peel 300g
木香 200克 Woody Fragrance 200g
南瓜子 300克 300g pumpkin seeds
(二)制备方法如下: (2) The preparation method is as follows:
1)按上述重量份配比取原料药; 1) Take the raw material medicine according to the above weight ratio;
2)加入赤芍、刺梨根、海桐皮、木香和南瓜子总重量10倍量水浸泡2小时,加热煎煮,沸后过滤;药渣再加8倍量水加热至沸,沸后过滤,滤液合并,得上清液; 2) Add Radix Paeoniae Rubra, Rosa Rosa Root, Pittosporum Peel, Woody Fragrance and Pumpkin Seeds, soak in 10 times the total weight of water for 2 hours, heat and decoct, and filter after boiling; add 8 times the amount of water to the dregs and heat until boiling, then boil After filtering, the filtrates were combined to obtain the supernatant;
3)上清液浓缩至相对密度为1.05时,进喷雾干燥器,进风温度控制130℃,出风温度110℃,进料速度为5ml/分钟,得喷雾干燥粉40克。 3) When the supernatant is concentrated to a relative density of 1.05, it enters the spray dryer, the inlet air temperature is controlled at 130°C, the outlet air temperature is 110°C, and the feed rate is 5ml/min to obtain 40g of spray-dried powder.
将喷雾干燥粉,按常规工艺可以制成口服制剂,如口服液、胶囊、片剂或冲剂等。 The spray-dried powder can be made into oral preparations, such as oral liquids, capsules, tablets or granules, etc. according to conventional techniques.
实施例3 具有促进排铅作用的中药组合物Embodiment 3 has the Chinese medicine composition that promotes the effect of excreting lead
(一)原料药重量份配比如下 (1) The weight ratio of raw materials is as follows
赤芍 120克 Radix Paeoniae Alba 120g
刺梨根 200克 Prickly pear root 200g
海桐皮 200克 Pittosporum peel 200g
木香 150克 Woody 150g
南瓜子 200克 200g pumpkin seeds
(二)制备方法如下: (2) The preparation method is as follows:
1)按上述重量份配比取原料药; 1) Take the raw material medicine according to the above weight ratio;
2)加入赤芍、刺梨根、海桐皮、木香和南瓜子总重量8倍量水浸泡2小时,加热煎煮,沸后过滤;药渣再加8倍量水加热至沸,沸后过滤,滤液合并,得上清液; 2) Add Radix Paeoniae Rubra, Rosa Rosa Root, Pittosporum Peel, Woody Fragrance and Pumpkin Seeds, soak in 8 times the total weight of water for 2 hours, heat and decoct, filter after boiling; add 8 times the amount of water to the dregs, heat to boil, and boil After filtering, the filtrates were combined to obtain the supernatant;
3)上清液浓缩至相对密度为1.06时,进喷雾干燥器,进风温度控制140℃,出风温度100℃,进料速度为5ml/分钟,得喷雾干燥粉25克。 3) When the supernatant is concentrated to a relative density of 1.06, it enters the spray dryer, the inlet air temperature is controlled at 140°C, the outlet air temperature is 100°C, and the feed rate is 5ml/min to obtain 25g of spray-dried powder.
将喷雾干燥粉,按常规工艺可以制成口服制剂,如口服液、胶囊、片剂或冲剂等。 The spray-dried powder can be made into oral preparations, such as oral liquids, capsules, tablets or granules, etc. according to conventional techniques.
实验例1:Experimental example 1:
选用60只健康昆明种小鼠,清洁级动物,雄雌各半,体重20±2克,分为5组,即空白对照组,染铅模型组,高、中、低中药组合物水煎液3个剂量组,每组12只,将醋酸铅溶于蒸馏水中按40mg/kg腹腔注射,建立小鼠染铅动物模型。 Select 60 healthy Kunming mice, clean animals, half male and half female, body weight 20 ± 2 grams, divided into 5 groups, namely blank control group, lead-exposed model group, high, medium and low Chinese medicine composition water decoction 3 dose groups, 12 rats in each group, dissolved lead acetate in distilled water and injected intraperitoneally at 40 mg/kg to establish a lead-exposed mouse model.
中药组合物水煎液采用常规水煎方法制备,并浓缩为相应浓度,水煎液不同剂量组包括高剂量组(40g/kg),中剂量组(20g/kg),低剂量组(10g/kg),各用药组灌胃给药,其余各组灌服等量的生理盐水,实验连续给药共8周。给药结束后取小鼠右股静脉血40ul,放入盛有0.36ml1%硝酸的带盖塑料离心管摇匀;取一侧50%股骨,称重后进行消化,加稀硝酸定容至5ml,同法相应取肝脏和脑组织,用原子分光光度计进行血和骨、肝铅含量测定;上述数据统计用T检验。 The decoction of the traditional Chinese medicine composition is prepared by a conventional decoction method, and concentrated to the corresponding concentration. The different dosage groups of the decoction include a high-dose group (40g/kg), a middle-dose group (20g/kg), and a low-dose group (10g/kg). kg), each drug group was administered by intragastric administration, and the other groups were administered with the same amount of normal saline, and the experiment continued for 8 weeks. After the administration, take 40ul of blood from the right femoral vein of the mouse, put it into a covered plastic centrifuge tube filled with 0.36ml of 1% nitric acid, and shake well; take 50% of the femur on one side, weigh it and digest it, add dilute nitric acid to make it to 5ml According to the same method, the liver and brain tissue were taken accordingly, and the blood, bone, and liver lead content were measured with an atomic spectrophotometer; the statistics of the above data were tested by T.
表1 本发明中药组合物水煎液对小鼠血铅、骨铅、肝和脑铅(mg/kg)含量影响( ±s,n=12) Table 1 Chinese medicine composition water decoction of the present invention is to mouse blood lead, bone lead, liver and brain lead (mg/kg) content influence ( ±s, n=12)
*代表与模型组对照比较P<0.01 Δ代表与空白组对照比较P<0.01 * represents P <0.01 compared with the model group control, Δ represents P <0.01 compared with the blank group control
中药组合物水煎液对血铅含量影响明显,各剂量组与模型组比较有显著性差异P<0.05;中药组合物水煎液对骨铅含量有影响,高剂量组与模型组比较有显著性差异P<0.05;中药组合物对肝铅含量影响明显,低中高剂量组与模型组比较有显著性差异P<0.05;中药组合物水煎液对脑铅含量影响明显,各剂量组与模型组比较有显著性差异P<0.05。 The water decoction of the traditional Chinese medicine composition has a significant effect on the blood lead content, and there is a significant difference between each dose group and the model group, P <0.05; P <0.05; the traditional Chinese medicine composition had a significant effect on the liver lead content, and there was a significant difference between the low, middle and high dose group and the model group, P <0.05; There was a significant difference between groups, P <0.05.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110265420 CN102302569B (en) | 2011-09-08 | 2011-09-08 | Chinese medicinal composition for promoting lead discharging effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110265420 CN102302569B (en) | 2011-09-08 | 2011-09-08 | Chinese medicinal composition for promoting lead discharging effect |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102302569A CN102302569A (en) | 2012-01-04 |
CN102302569B true CN102302569B (en) | 2013-01-23 |
Family
ID=45376552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110265420 Expired - Fee Related CN102302569B (en) | 2011-09-08 | 2011-09-08 | Chinese medicinal composition for promoting lead discharging effect |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102302569B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101642271A (en) * | 2008-08-04 | 2010-02-10 | 北京科技桥科贸有限公司 | Spiny pear beverage |
-
2011
- 2011-09-08 CN CN 201110265420 patent/CN102302569B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101642271A (en) * | 2008-08-04 | 2010-02-10 | 北京科技桥科贸有限公司 | Spiny pear beverage |
Non-Patent Citations (4)
Title |
---|
中医药治疗铅中毒的文献研究分析;任平等;《河南中医学院学报》;20090315;第24卷(第02期);82-85 * |
中草药排铅领域之研究概况;张俊清等;《中国职业医学》;20020830;第29卷(第04期);50-51 * |
任平等.中医药治疗铅中毒的文献研究分析.《河南中医学院学报》.2009,第24卷(第02期),82-85. |
张俊清等.中草药排铅领域之研究概况.《中国职业医学》.2002,第29卷(第04期),50-51. |
Also Published As
Publication number | Publication date |
---|---|
CN102302569A (en) | 2012-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104887952B (en) | A composition with the effect of nourishing yin and moistening the lung and its preparation method and application | |
CN101297889A (en) | Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof | |
CN102258628B (en) | Chinese medicinal composition with lead removal promoting effect | |
CN106620475B (en) | Traditional Chinese medicine composition for preventing and treating diabetes cognitive impairment and preparation method thereof | |
CN106266239A (en) | Improve compositions of memory and its preparation method and application | |
CN103638199B (en) | A kind ofly prevent and treat Chinese medicine composition of neurasthenia and senile dementia and preparation method thereof | |
CN117599125A (en) | A Chinese medicinal composition for supplementing calcium and strengthening bones for treating osteoporosis, and its preparation method and application | |
CN108721431A (en) | A kind of Chinese medicine composition of re-scheduling metal and its application | |
CN102302569B (en) | Chinese medicinal composition for promoting lead discharging effect | |
CN111558019B (en) | Traditional Chinese medicine composition with effects of benefiting qi, nourishing blood, regulating menstruation and relieving pain and preparation method and application thereof | |
CN102106999A (en) | Chinese medicinal compound preparation for treating dysphagia due to stroke and preparation method thereof | |
CN102727627B (en) | Traditional Chinese medicine composition for treating heart failure and preparation method and application thereof | |
CN101804119B (en) | Traditional Chinese medicine preparation for treating thrombocytopenia and preparation method thereof | |
CN100350954C (en) | Chinese medicine preparation for promoting lead-removal and its preparation process | |
CN100394947C (en) | Pharmaceutical composition and preparation method for treating cervical spondylosis | |
CN102327386B (en) | A traditional Chinese medicine composition for promoting lead discharge and preparation method thereof | |
CN111419970A (en) | Traditional Chinese medicine composition for treating myocarditis | |
CN110339323A (en) | A kind of Chinese medicine composition and its preparation method and application for treating bradycardia | |
CN102631496B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
CN104524359B (en) | A kind of Chinese medicine composition, its preparation method and application | |
CN102935132B (en) | Lead removing traditional Chinese medicine composition | |
CN103933476B (en) | It is a kind of to treat pharmaceutical composition of intercostal neuralgia and its production and use | |
CN1554390A (en) | A traditional Chinese medicine preparation for treating Sjogren's syndrome and its preparation method | |
CN102727757B (en) | Application of Chinese Ladiestresses Root or Herb in preparation of either medicines or healthcare products capable of promoting lead-expelling effect | |
CN101919984A (en) | A kind of medicine for treating hyperthyroidism and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130123 Termination date: 20150908 |
|
EXPY | Termination of patent right or utility model |